Exploring ageing as a potential new therapeutic target for schizophrenia.
Exploring ageing as a potential new therapeutic target for schizophrenia.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Barcelona, ES · Author affiliation
Barcelonabeta Brain Research Center, Barcelona, Spain.Location evidence
Leicester, GB · Author affiliation
Division of Molecular and Cell Biology, University of Leicester, UK.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Increased age-related biological changes have been causally linked to various pathologies in the brain, including Alzheimer's and Parkinson's diseases. There is also evidence that schizophrenia could be included in this group of brain disorders that may actually be manifestations of a broader multisystemic premature ageing phenotype.